The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-(2,3-dihydroimidazo[2,1-b]thiazol-6-yl)ethyl)-5-imino-5H-thiazolo[3,2-a]pyrimidine-6-carboxamide ID: ALA5290718
Max Phase: Preclinical
Molecular Formula: C14H14N6OS2
Molecular Weight: 346.44
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N=c1c(C(=O)NCCc2cn3c(n2)SCC3)cnc2sccn12
Standard InChI: InChI=1S/C14H14N6OS2/c15-11-10(7-17-13-20(11)4-6-22-13)12(21)16-2-1-9-8-19-3-5-23-14(19)18-9/h4,6-8,15H,1-3,5H2,(H,16,21)
Standard InChI Key: YTRALBVYDVDYCR-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
1.4579 1.2805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1725 1.6928 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8844 1.2809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8844 0.4557 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1743 0.0440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4579 0.4520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6886 1.5311 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.1594 0.8774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6674 0.2098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1743 -0.7812 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7433 0.0394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7433 -0.7856 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0287 0.4520 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6859 0.0394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4005 0.4520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1151 0.0394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1151 -0.7856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9193 -1.0358 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.3901 -0.3821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8980 0.2853 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.4136 -1.6928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1594 -1.4436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1505 -0.6341 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 2 0
4 3 1 0
5 4 1 0
1 6 2 0
6 5 1 0
3 7 1 0
7 8 1 0
9 8 2 0
4 9 1 0
5 10 2 0
6 11 1 0
11 12 2 0
11 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
17 16 2 0
17 18 1 0
18 19 1 0
20 19 2 0
16 20 1 0
18 21 1 0
21 22 1 0
23 22 1 0
19 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 346.44Molecular Weight (Monoisotopic): 346.0671AlogP: 1.15#Rotatable Bonds: 4Polar Surface Area: 88.07Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.59CX LogP: 1.08CX LogD: 1.08Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.74Np Likeness Score: -2.29
References 1. Sethi A, Sanam S, Alvala M.. (2021) Non-carbohydrate strategies to inhibit lectin proteins with special emphasis on galectins., 222 [PMID:34146913 ] [10.1016/j.ejmech.2021.113561 ]